Viewing Study NCT06361758


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-02-12 @ 9:51 PM
Study NCT ID: NCT06361758
Status: WITHDRAWN
Last Update Posted: 2025-05-23
First Post: 2024-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC
Sponsor: Shanghai Zhongshan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module